The Ultimate Resource for Pharmaceutical SOPs and Best Practices
This SOP defines the procedures for conducting preformulation studies for capsule dosage forms to ensure the selection of suitable excipients, formulation parameters, and to optimize the development process for capsule formulations.
Click to read the full article.
This SOP defines the procedure for conducting compatibility studies between active pharmaceutical ingredients (APIs) and excipients to ensure that no interactions or incompatibilities affect the performance, stability, or safety of the final capsule formulation.
Click to read the full article.
The purpose of this SOP is to outline the procedure for developing capsule fill formulations, ensuring that the formulations meet regulatory, quality, and performance standards for safe and effective use.
Click to read the full article.
The purpose of this SOP is to outline the procedure for screening and selecting polymers suitable for capsule coating to ensure optimal capsule performance, including controlled release, stability, and protection of the active pharmaceutical ingredient (API).
Click to read the full article.
The purpose of this SOP is to outline the procedure for conducting solubility studies for soft gelatin capsules to assess the dissolution behavior and bioavailability of the encapsulated active pharmaceutical ingredient (API).
Click to read the full article.
The purpose of this SOP is to establish the procedure for designing clinical trial batches of capsules, ensuring the development of an appropriate and scalable formulation for clinical testing while maintaining regulatory compliance and safety standards.
Click to read the full article.
This SOP outlines the procedure for developing prototype capsule dosage forms, ensuring that they meet the desired pharmacological properties, stability, and manufacturability criteria for further scale-up and clinical trials.
Click to read the full article.
The purpose of this SOP is to establish the procedure for optimizing the fill volume in capsule manufacturing, ensuring accurate and consistent dosage while minimizing material waste and production errors.
Click to read the full article.
The purpose of this SOP is to outline the procedure for conducting bioequivalence studies for capsule dosage forms to demonstrate that a generic formulation performs similarly to the reference (innovator) product in terms of bioavailability and therapeutic effectiveness.
Click to read the full article.
The purpose of this SOP is to outline the procedure for conducting rheological studies on gelatin to determine its flow properties, which are critical for capsule shell formulation, texture, and performance during manufacturing.
Click to read the full article.